Dr. Ted (Tae Heum) Jeong has more than 20 years of experience as a venture capitalist and a financial executive. He is a Managing Partner and Co-founder of KSV Global Innovations, a growth-stage investment firm. Before becoming CFO of Clene, Ted was previously CFO of Rexahn Pharmaceuticals, Inc. (Nasdaq: REXN), an oncology and CNS-focused biopharmaceutical company from 2002 to 2018. He completed equity financings totaling more than $170 million. He was also responsible for forming strategic alliances and executing license deals in the U.S., Europe, and Asia. From 1997 to 2002, he served as the Senior Investment Manager at Hyundai Venture Investment Corporation, a subsidiary of the Hyundai Motors conglomerate and one of the largest venture capital firms in South Korea, where he operated two of the first healthcare venture capital funds in Korea. Dr.Jeong received his B.S. and M.S. in Chemistry from Pohang University of Science & Technology. He also holds an M.S. in Finance from Johns Hopkins University, and a Doctor of Management from the University of Maryland. He currently serves on the Board of Directors of Neurobo Pharmaceuticals (Nasdaq: NRBO) as chair of the audit committee.